Biocon Ltd. — Regulatory Filings 2020

Apr 22, 2020

==> picture [132 x 52] intentionally omitted <==

Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417 www.biocon.com

April 22, 2020

To To The Secretary The Secretary BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol - Biocon

Dear Sir/Madam,

Subject: Intimation for the Board Meeting and Trading Window Closure

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 14, 2020, inter alia, to approve and take on record the audited standalone and consolidated financial results for the quarter and year ended March 31, 2020 amongst other routine matters.

The trading window for dealing in securities of the Company for all insiders, as defined under the Code of Conduct for Prevention of Insider Trading (‘the Code’) of the Company, has been closed from April 1, 2020 to May 16, 2020 (both days inclusive) in compliance with the provisions of the Code of the Company read with SEBI (Prohibition of Insider Trading) Regulations.

The above-mentioned information will also be available on website of the Company at www.biocon.com.

Request you to take the above intimation on record.

Thanking You,

For Biocon Limited

==> picture [97 x 37] intentionally omitted <==

---

==> picture [77 x 82] intentionally omitted <==

Mayank Verma

Company Secretary and Compliance Officer